Plant-produced African Horse Sickness Virus Novel VaccineAugust 23, 2017
African horse sickness (AHS) is a serious and often fatal viral disease affecting horses in Africa, caused by the dsRNA orbivirus African horse sickness virus (AHSV). Although vaccination is the most effective weapon in battling AHS, the available vaccine is a live-attenuated version of the virus (LAV). This constraint spurred attempts to develop an alternative vaccine.
The team of Susan J. Dennis from the University of Cape Town in South Africa reports a plant-based production of a virus-like particle (VLP) AHSV serotype five candidate vaccines. The team transformed AHSV capsid proteins into tobacco (Nicotiana benthamiana) via Agrobacterium-mediated transformation. The vaccine was extracted and purified from the leaves of tobacco plants containing all four capsid proteins.
Guinea pigs were used to test the ability of the plant-produced AHSV vaccine to induce an immune response. Five guinea pigs were each treated with AHSV vaccine. All vaccinated guinea pigs showed a level of neutralization capability against AHSV. These results indicate that plant-produced AHSV vaccine can stimulate a high immune response in guinea pigs.
This study is the first reported of AHSV vaccine produced in plants, which has important implications for the fight against AHSV.
For more information, read the article in Plant Biotechnology Journal.
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Terminology Matters in Biosafety Communication
- Biologists Show How Plants Turn Off Genes They Don't Need
- Researchers Describe Gene that Makes Large, Plump Tomatoes
- Australian OGTR Receives License Application for Commercial Release of GM Cotton
- Vietnam Will Have to Continue Importing Maize
- Davao Stakeholders Updated on Crop Biotech and Philippine Biosafety Guidelines
- Green Revolution Genes Promise More Yield
- GmSN1 Overexpression Enhances Virus Resistance in Arabidopsis and Soybean
- Role of PtrZPT2-1 Gene in Plant Tolerance to Multiple Abiotic Stresses
Plant Breeding Innovations
- Targeted Mutagenesis in Tetraploid Switchgrass
- CRISPR-Cas9 Genome Editing in Rapeseed
Beyond Crop Biotech
- Plant-produced African Horse Sickness Virus Novel Vaccine
From the BICs
- DA-Davao Info Officers Explore Social Media for Sharing Agri Innovations
- PARC Adopts New Techniques for Agricultural Development in Pakistan
- Updated Pocket Ks on Biotech Now Available
Read the latest:
- Crop Biotech Update (September 28, 2022)
- Genome Editing Supplement (September 21, 2022)
- Gene Drive Supplement (September 28, 2022)
Subscribe to CBU: